“Although NJOY Daily is not subject to these orders, JUUL has asserted claims of patent infringement based on the sale of NJOY Daily in the United States.”10-Q · Apr 30, 2026 ↗
Altria Group, Inc.
MO
Market read
Altria Group, Inc.'s move is being confirmed by its market group.
No new filing conclusion is available. 9 of 35 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 10 directly disclosed connections are confirming.
- At least 23 of 35 durable members become active together.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as HELE begins moving with the group.
Invalidation: The live read weakens if participation falls to 12 of 35 members or fewer.
Research brief
The story so far
No new filing conclusion is available. 9 of 35 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 10 directly disclosed connections are confirming.
No thresholded supportive filing evidence is available yet.
No thresholded adverse filing evidence is available yet.
- At least 23 of 35 durable members become active together.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as HELE begins moving with the group.
Company research
Understand the business, not just the ticker
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
- Operating cash flow covered net income at 1.34x in the latest annual period.
- Latest annual revenue changed -3.1% year over year.
- Operating margin changed -4.3 percentage points in the latest annual period.
- Net margin changed -17.1 percentage points in the latest annual period.
- Restructuring and cost reductions has repeated adverse evidence across 3 filings.
- P/E is 36% below the available filing-peer median; determine whether growth and quality justify the difference.
- EV/sales is 19% below the available filing-peer median; determine whether growth and quality justify the difference.
Price as of Sep 11, 2026
68.97Reported annual revenue and per-share history. This is accounting history, not a forecast.
What management says matters
Persistent and emerging business drivers
“Marketing, administration and research costs decreased $38 million (6.5%), due primarily to lower tobacco and health and certain other litigation items, lower amortization of intangibles, lower general corporate expenses and lower costs related to our Optimiz…”10-Q · Apr 30, 2026 ↗
“The payments due under the terms of the State Settlement Agreements and FDA user fees are subject to adjustment for several factors, including inflation, operating income, market share and volume.”10-Q · Apr 30, 2026 ↗
“Three Months Ended March 31, 2026 Compared with Three Months Ended March 31, 2025 Net revenues, which include excise taxes billed to customers, increased $15 million (2.3%), as higher pricing ($47 million), which includes higher promotional investments, was p…”10-Q · Apr 30, 2026 ↗
Valuation discipline
Descriptive valuation snapshot
Price/sales 5.0× · EV/sales 5.8×. Comparisons use only industry-matched filing peers.
Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.
Price action
How the market is pricing the story
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for MO. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Filing analysis
No comparable filing assessment is available yet
Jodie has not yet found a suitable current-versus-prior filing comparison for MO. This does not mean the latest filing was neutral or immaterial.
Business ecosystem
The relationships behind MO
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
PMPhilip Morris International Inc.customerOct 30, 2025 ▾
“In combustibles, we own Philip Morris USA Inc.”
CRONFiling-linked nameinvesteeOct 30, 2025 ▾
“t the expected benefits of our investment in ABI may not materialize in the expected manner or timeframe or at all; and ▪ the risks associated with our investment in Cronos, including legal, regulatory and reputational risks and the risk that the expected ben…”
Depended on by
PMPhilip Morris International Inc.competitorFeb 6, 2026 ▾
“Competitors in our industry include Altria Group, Inc., British American Tobacco plc, Japan Tobacco Inc., Imperial Brands plc, new market entrants, particularly with respect to innovative products, several regional and local tobacco companies and, in some ins…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 9 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
MO is currently a Participant in the organic co-movement group Packaged Foods & Beverages. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.